The Ministry of Health in Argentina (ANMAT) has revised the form used to manage the import of materials and equipment intended for Clinical Research Pharma. The new simplified form will require completion of only “12 points” instead of “15 points”.
GDP guidelines are designed specifically to regulate the distribution of medicinal products from the manufacturer to the end user -- the patient. The fact that drug distribution reaches to every corner of the world today means there are more stakeholders involved in the process.
The Indian government has allowed for easier import and export of various biological samples by removing the mandatory requirement of an export and import license for these samples, announced Mr Anup Wadhawan, Director General of Foreign Trade (DGFT), on August 4, 2016. The new ruling will save CROs, biotech companies and research centers significantly shorter import and export approval times.
Comprehensive solution for a Pharmaceutical Organization shipping API, Bulk Drug and Biological Samples across six continents.
To secure appropriate packaging and transport a bulk drug substance of a critical nature and value from Shanghai, China to Pennsylvania, USA maintaining Controlled Temperature conditions.
Transportation of biologicals has become increasingly challenging. Understanding DG classification requirements is critical to ensure you are in compliance with the law.
Planning is the key to successful and efﬁcient Cold Chain Distribution. Yet many companies still miss out on opportunities to save money and increase overall efﬁciency.